美股A股
StockGist
Back
10-K/A2026-04-29· deepseek-chat

SNTI · Senti Biosciences, Inc.

0001628280-26-028429

SEC filing

Summary

A transitional year marked by continued operating losses and cash burn, with strategic financing and restructuring progress.

Full analysis

Executive Compensation and Alignment

Financing and Capital Structure

Severance and Retention Provisions

Retirement and Benefits

The company maintains a 401(k) plan with employer matching contributions for all employees, including named executive officers. No pension or nonqualified deferred compensation plans exist. Health and welfare benefits are provided on a uniform basis, with the company paying premiums for life, disability, and accidental death insurance.

Ownership and Governance